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Adult tissues undergo continuous cell turnover in response to
stress, damage, or physiological demand. New differentiated cells
are generated from dedicated or facultative stem cells or from
self-renewing differentiated cells. Here we describe a different
stem cell strategy for tissue maintenance, distinct from that ob-
served for dedicated or facultative stem cells. We report the
presence of nestin-expressing adult stem cells in the perilumenal
region of the mature anterior pituitary and, using genetic inducible
fate mapping, demonstrate that they serve to generate subsets of
all six terminally differentiated endocrine cell types of the pituitary
gland. These stem cells, while not playing a significant role in
organogenesis, undergo postnatal expansion and start producing
differentiated progeny, which colonize the organ that initially
entirely consisted of differentiated cells derived from embryonic
precursors. This generates a mosaic organ with two phenotypically
similar subsets of endocrine cells that have different origins and
different life histories. These parallel but distinct lineages of
differentiated cells in the gland may help the maturing organism
adapt to changes in the metabolic regulatory landscape.
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T issue maintenance in the adult organism requires a constantsupply of new cells to replace differentiated cells lost to stress
and damage or destroyed as part of a normal cell death program.
This replacement is made possible through the activity of
tissue-specific dedicated stem cells (exemplified by stem cells for
blood, hair follicles, and brain), facultative stem cells (e.g., oval
cells of the liver producing hepatocytes upon injury), or fully
differentiated cells, which can undergo self-duplication when
required for tissue maintenance (e.g., hepatocytes and pancre-
atic  cells) (1, 2). For both the dedicated and facultative stem
cells of the adult tissues, the lineage can be traced back to
particular embryonic precursors; these same embryonic precur-
sors are also responsible for the generation of differentiated cells
of the tissue.
Anterior pituitary gland is a key regulator of the endocrine
balance in the adult organism. The gland of newborns already
contains a full set of terminally differentiated hormone-
producing cells (3, 4). However, the postnatal gland undergoes
extensive remodeling during the lifetime of the animal. Soon
after birth, the anterior pituitary enters a phase of growth that
results in a dramatic increase in the size of the gland (5, 6).
Furthermore, composition of the gland undergoes changes in
response to hormonal signals (7). These observations are com-
patible with the existence of stem-like cells in the maturing and
adult pituitary; this notion is also supported by observations that
a fraction of pituitary tumors of monoclonal origin are pluri-
hormonal and contain several pituitary cell types (8, 9). How-
ever, the existence of multipotent stem cells in the anterior
pituitary has not yet been demonstrated. Several different cell
types, including folliculostellate cells (10–13), rapidly dividing
nestin-expressing cells (14), and side population cells of the
anterior pituitary (15), have been recently proposed as stem cells
(16); however, there is no evidence that any of the proposed
candidates are able to generate all differentiated cell types and
participate in the process of cell renewal in the anterior pituitary
gland in vivo. We here demonstrate the existence of stem cells
in the adult pituitary and describe a distinct strategy that these
stem cells employ.
Results
Nestin-Expressing Cells of the Adult Anterior Pituitary. To identify
stem cells of the anterior pituitary, we used transgenic mice
expressing GFP driven by regulatory elements of the nestin gene
(17). Expression of this transgene has been found in several types
of tissue-specific multipotential stem cells, including adult and
embryonic neural stem cells (17), stem cells in the bulge of the
hair follicles (18, 19), precursors to the Leydig cells of the testis
(20), satellite cells of the skeletal muscles (21), and oval cells in
the liver (22). We therefore examined whether nestin-GFP
expression may also mark stem cells for the pituitary gland. We
found GFP-positive cells in both the anterior and intermediate
lobes of the pituitary gland of 3- to 4-week-old mice, residing
predominantly around the lumen that separates the anterior and
intermediate lobes (Fig. 1 A and B); identical results were
obtained with an independently generated mouse line (23)
carrying cyan fluorescent protein fused to a nuclear localization
signal driven by the same regulatory elements (data not shown).
A smaller number of such cells was found at the border between
the intermediate and posterior lobes. The GFP-positive cells
expressed Lhx3 (Fig. 1C), a key marker of all six pituitary
lineages (24, 25), suggesting a histogenetic relation to the
endocrine cell types of the pituitary. They also expressed Sox2,
whose expression is associated with several categories of stem
cells; furthermore, they express epithelial markers cytokeratin 8
and EpCAM (Fig. 1 D and E). The nestin-GFP cells were
negative for the markers of terminal differentiation of the
pituitary lineages, indicating their undifferentiated phenotype.
A smaller number of weakly GFP-positive cells, presumably of
mesenchymal origin, did not express Lhx3, cytokeratin 8, or
EpCAM and were mostly found associated with blood vessels
(Fig. 1F).
To obtain further insights into the genesis of the nestin-GFP
cells of the adult gland, we traced the development of these cells
during the embryonic and perinatal periods of pituitary histo-
genesis. The first nestin-GFP-expressing cells were detected in
Rathke’s pouch, the primordium of the anterior pituitary, at
embryonic day 11.5. At this time, single GFP-expressing cells
were located in the dorsal part of Rathke’s pouch, the region that
contributes to the future intermediate and anterior lobes of the
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anterior pituitary (Fig. 1G). At the end of embryonic develop-
ment and immediately after birth [embryonic day 18.5 to post-
natal day 1 (p1)], the number of GFP-expressing cells gradually
increased, and they were still confined mostly to the perilumenal
areas. As in the adult pituitary, these cells were positive for Lhx3
and for the epithelial markers cytokeratin 8 and EpCAM (Fig.
1H); however, they did not express markers of terminal
differentiation.
At the end of the first postnatal week, the pituitary gland starts
to undergo a second wave of growth accompanied by a dramatic
increase in cell proliferation. At this time, we observed a
significant migration of GFP-expressing cells that expressed
cytokeratin 8, EpCAM, and Lhx3, from the perilumenal area
into the glandular territory. (Fig. 1I). Among these cells, a small
fraction also expressed Pit-1; these cells may correspond to a
transitory form between the multipotent stem cells and their
more narrowly committed progeny. A large fraction of nestin-
GFP-expressing cells both in the glandular zone and in the
perilumenal area was positive for Ki67, a marker of dividing
cells. Importantly, such active migration and proliferation of
nestin-GFP cells was observed only for this period of pituitary
development. It was not seen immediately after birth (p1) or at
the end of the second wave of pituitary growth (p21) (Fig. 1J).
Genetic Lineage Marking of the Nestin-GFP Stem Cells. The obser-
vations of the stem-like nature and phenotype of nestin-GFP
cells, their dissimilarity from the embryonic pituitary precursors,
and their involvement in the postnatal wave of pituitary growth
together suggest that nestin-GFP cells correspond to the multi-
potent stem cells of the adult pituitary. They further suggest that
these cells are different from the embryonic precursors that
generate the bulk of the cells that make up the gland during
embryonic development. We sought to support this hypothesis
by using a lineage analysis technique that employs a recombi-
nation-based reporter system in which transgenic mice express-
ing Cre recombinase under the control of nestin regulatory
elements, the same elements used to generate the nestin-GFP
line (26), are crossed with mice of the ROSA26-loxP-stop-loxP-
GFP (ROSA-lsl-GFP) reporter line. In the progeny, the differ-
entiated cells that are derived from nestin-expressing precursors
(which have undergone Cre-mediated recombination) will be
permanently marked by GFP expression.
In the pituitary of newborn nestin-Cre/ROSA-lsl-GFP mice, we
found scattered terminally differentiated GFP-positive cells in the
intermediate and anterior lobes. The most significant contribution
of GFP-positive cells to the newborn gland was in the rostral tip of
the pituitary, a transient structure that disappears soon after birth
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Fig. 1. Nestin-GFP cells in the adult and developing pituitary. (A) General view of adult mouse pituitary. PL, posterior lobe of pituitary; IL, intermediate lobe;
AL, anterior lobe. An arrow indicates the lumen that separates intermediate and anterior lobes. The perilumenal area is a remnant of embryonic primordium
of the anterior pituitary, Rathke’s pouch. (B) In the pituitary of nestin-GFP transgenic mice the majority of GFP-positive cells are located in the perilumenal area
(arrows). Several GFP-positive cells are seen at the border separating intermediate and posterior lobes (arrowhead). (C–F) GFP-positive cells express Lhx3 (C,
arrows), EpCAM (D), and Sox2 and cytokeratin 8 (E). GFP expression was also found in the cells with long processes that were dispersed throughout the gland
and did not express Lhx3 (F, arrow). [Scale bars: 400 m (A), 35 m (B) and 10 m (C–F).] (G) Nestin-GFP-positive cells in the primordium of the anterior pituitary,
Rathke’s pouch (RP; Di, ventral diencephalon), are first detected at embryonic day 11.5 (Left). They localized in the upper portion of Rathke’s pouch and express
epithelial markers, such as EpCAM (Right, arrows). [Scale bars: 50 m (Left) and 12.5 m (Right).] (H) At p0, GFP-positive cells are seen almost exclusively in the
perilumenal area of pituitary (Upper Left) and are Lhx3-positive (Upper Right), cytokeratin 8-positive (Lower Left), and EpCAM-positive (Lower Right). [Scale
bars: 75 m (Upper Left) and 15 m (Upper Right and Lower).] (I) A significant number of GFP-positive cells is seen in pituitary parenchyma at p7 (Upper Left)
at the beginning of the postnatal wave of the pituitary growth. These cells express cytokeratin 8 (Upper Right, arrows), Lhx3 (Lower Left, arrows), and EpCAM
(Lower Right, arrows). (J) Proliferation of transgene-positive cells. At p0, transgene-positive cells located in perilumenal zone are negative for Ki67, a marker
of proliferation (Left, arrowheads). Later, during a postnatal wave of pituitary growth nestin-GFP-positive cells that migrate into glandular zone are often
positive for Ki67, a marker of proliferation (Center, arrows, p7). At p21, the majority of transgene-positive cells reside in the perilumenal zone. They are negative
for Ki67 (Right, arrowhead). (Scale bars: 15 m.)
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(Fig. 2A).Not counting these cells, the number ofGFP-positive cells
in the newborns was only2% (Fig. 2A andC). This demonstrates
that the bulk of the pituitary cells derived from cells that did not
express nestin at any stage of their development, supporting our
hypothesis that nestin-expressing cells represent a separate lineage
of pituitary precursors.
Providing further support for the notion of nestin-positive cells
serving as adult stem cells, the number of GFP-positive cells in
both the intermediate and anterior lobes of the pituitary grad-
ually increased after birth and reached 20% of all cells of the
anterior pituitary by 5 months of age (Fig. 2 B and C). GFP
expression was found in all six terminally differentiated pituitary
endocrine cell types—melanotrophs, corticotrophs, gonado-
trophs, somatotrophs, lactotrophs, and thyrotrophs (Fig. 2D).
Thus, the input of adult stem cells increases 10-fold during the
first months of life, highlighting their contribution to the struc-
ture of the adult gland.
Further supporting the notion of a separate adult stem cell
lineage, the differentiation choices differed between the embry-
onic- and adult stem cell-derived progeny; for instance, in
females the ratio of lactotrophs to somatotrophs was 1.8 times
higher for GFP-expressing cells (i.e., cells derived from the
presumptive adult stem cells) than for all of the cells of the gland
(a mix of embryonic- and adult-generated cells), whereas in
males it was 0.7 times lower for the GFP-expressing cells as
compared with all cells of the gland (Fig. 2C). Together, these
results indicate that a substantial fraction of the differentiated
cells in the adult pituitary derive from adult, but not embryonic,
stem cells and demonstrate complex dynamics of the stem
cell-derived population in the gland.
It is potentially possible that differentiated cells in the above
experiments derive from committed progenitor cells with a more
limited differentiation repertoire that persist in the adult gland,
rather than from multipotential stem cells. To discriminate
between these possibilities, we used another lineage-marking
approach, genetic inducible fate mapping (27), where the same
ROSA-lsl-GFP reporter mice were crossed with animals express-
ing Cre recombinase fused to the tamoxifen-responsive estrogen
receptor ligand binding domain under the control of the nestin
gene regulatory elements that had been used to generate the
nestin-Cre and nestin-GFP lines (28). In the progeny, recombi-
nation, and thus GFP expression, occurs upon addition of
tamoxifen and activation of the recombinase; thus, it is possible
to achieve a temporal control over the initiation of the lineage
analysis. We found that, even in animals of advanced age (10
months), tamoxifen-induced marking revealed terminally differ-
entiated endocrine cells (Fig. 2E). (Note that tamoxifen-induced
recombination may be effective in a fraction of potential target
cells; thus, we cannot quantify the overall contribution of adult
stem cells using this approach.) These results confirm that new
differentiated cells are generated in the adult gland and indicate
that these cells are derived from nestin-positive multipotential
stem cells.
Nestin-GFP Cells Generate Pituitary Lineages in Vitro. To extend this
in vivo evidence of the presence of multipotent stem cells in the
anterior pituitary gland, we developed a protocol for isolation
and cultivation of nestin-GFP-expressing cells from the adult
pituitary [Fig. 3 and supporting information (SI) Fig. S1]. These
cells can give rise to exponentially growing colonies. There are
1,000 clonogenic cells in the adult anterior pituitary gland,
representing 0.1–0.2% of the cells in the gland. These clono-
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Fig. 2. Nestin-expressing precursors/stem cells contribute to all six terminally
differentiated cell types in the anterior pituitary. (A) GFP-positive cells are
seen in the brain and pituitary gland of newborn (p0) nestin-cre recombinase
transgenic mice crossed with the ROSA-lsl-GFP reporter strain. H, hypothala-
mus; AP, anterior pituitary; RT, rostral tip of the anterior pituitary. In the
anterior pituitary, a few cells express GFP. The majority of rostral tip thyro-
trophs are GFP-positive. Note that the majority of the differentiated neurons
in the hypothalamus are GFP-positive, which indicates the effectiveness of
Cre-induced recombination in neural stem cells. The expression of GFP in this
particular mouse reporter line is weak but can be effectively visualized with
anti-GFP antibodies. (Scale bar: 75 m.) (B) Accumulation of GFP-positive cells
in the anterior pituitary of nestin-Cre transgenic mice crossed with ROSA-lsl-
GFP reporter mice. The number of GFP-positive cells reaches a peak around
age 5 months. Female pituitaries (Upper) contain significantly higher numbers
of GFP-positive cells than males (Lower). (Scale bar: 400m.) (C) Accumulation
of nestin-Cre-derived cells in the anterior pituitary is age- and sex-dependent.
The percentage of GFP-expressing cells gradually increases between 2.5 and 5
months. Between ages 5 and 8 months, a significantly higher number of stem
cell-derived differentiated cells was found in the female anterior pituitary.
Male pituitaries contain almost twice the percentage of somatotrophs in
comparison with lactotrophs, whereas female pituitaries contain many more
lactotrophs than somatotrophs. Correspondingly, the majority of GFP-positive
progeny of nestin-expressing stem cells in males differentiated into soma-
totrophs, whereas in female most of them became lactotrophs. (D) GFP-
positive cells contribute to each endocrine lineage: melanotrophs in the
intermediate lobe and corticotrophs in the anterior lobe, visualized with
anti-MSH and anti-ACTH antibodies correspondingly; gonadotrophs (anti-
GSU antibody); and Pit-1-dependent cell lineages (anti-Pit-1 antibody) that
include somatotrophs (anti-GH antibody), lactotrophs (anti-PRL antibody),
and thyrotrophs (anti-TSH antibody). Yellow shows colocalization of trans-
gene and corresponding marker. (Scale bar: 30 m.) (E) Nine-month-old mice
carrying Cre-ER fusion protein driven by the nestin regulatory elements and
the ROSA-lsl-GFP transgene were treated with tamoxifen twice with a 24-h
interval and killed 1 month later. Expression of GFP reporter was found in
perilumenal precursors as well as in terminally differentiated cells—ACTH-
positive, GSU-positive, and Pit-1-positive cells (fourth image). [Scale bars: 60
m (first image) and 30 m (other images).]
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genic cells can undergo at least 25 divisions, suggesting that they
may have stem cell-like properties.
During exponential growth, cells of the colony express the
same markers as the nestin-GFP cells of the pituitary gland
(GFP, nestin, Sox2, cytokeratin 8, cytokeratin 18, Lhx3, and
EpCAM), but they do not express markers of pituitary differ-
entiation (see also SI Text). When the cells of the colony exit the
exponential growth phase, they start to differentiate and can
produce cells of all six anterior pituitary lineages: scattered cells
in the colony express adrenocorticotrophic hormone (ACTH),
-subunit (GSU) of the glycoproteins follicle-stimulating hor-
mone (FSH), luteinizing hormone (LH), and thyroid-stimulating
hormone (TSH), and Pit-1, a POU-homeodomain transcription
factor that determines the differentiation of somatotrophs,
lactotrophs, and thyrotrophs; furthermore, we found cells ex-
pressing growth hormone (GH), prolactin (PRL), and TSH,
which mark terminal differentiation of the somatotrophs, lac-
totrophs, and thyrotrophs, respectively (Fig. 3). These results
were confirmed by RNA expression analysis (see SI Text). Thus,
nestin-GFP cells isolated from the anterior pituitary are undif-
ferentiated and capable of self-renewal and, upon prolonged
cultivation, can produce differentiated cells of all anterior pitu-
itary lineages. Together, these results provide additional evi-
dence that nestin-GFP cells of the anterior pituitary correspond
to stem cells of the adult gland.
Nestin-GFP Stem-Like Cells in Pituitary Tumors. An emerging con-
cept in the biology of stem cells is their potential connection to
carcinogenesis (1, 29, 30). Because nestin-expressing stem cells
in the anterior pituitary are the only cell type in the organ that
possesses a self-renewal potential, we speculated that these cells
may be targeted for the initiation of pituitary tumorigenesis. An
attractive genetic model of neuroendocrine tumorigenesis are
mice that carry one functional allele of retinoblastomaRb-1 gene
(Rb/ mice). These animals develop tumors in the interme-
diate lobe of the pituitary during the second year of life in almost
100% of cases (31, 32). We, therefore, crossed nestin-GFP mice
with Rb/ mice to investigate whether cells with a phenotype
similar to adult pituitary stem cells could be found in the
pituitary tumors. We found well developed tumors growing from
the intermediate lobes of 12-month-old Rb/ mice, and con-
sisting of multiple nodules or foci of proliferating endocrine cells
(Fig. 4 A and B), predominantly producing melanocyte-
stimulating hormone (MSH). Tumor nodules were surrounded
by nestin-GFP-positive cells that expressed Lhx3, Sox2, EpCAM,
and cytokeratin 8; in contrast to the majority of tumor cells these
cells were MSH-negative (Fig. 4 C–F). The similarity of the
phenotype of nestin-GFP-positive cells in the pituitary tumors
and the adult anterior pituitary stem cells we described above, as
well as their spatial distribution inside tumors, is consistent with
their representing an undifferentiated cell compartment con-
nected to the initiation and growth of pituitary tumors and with
the concept of cancer stem cells.
Discussion
We here describe a population of cells in the adult anterior
pituitary that satisfy the criteria for adult organ-specific
A
D
G
C
I
F
B
H
E
Fig. 3. Nestin-GFP-positive cells can self-renew and differentiate along all
pituitary lineages in vitro. (A) Epithelial colonies grown from nestin-GFP
transgenic mice undergo spontaneous differentiation after exiting from ex-
ponential growth. At day 8, the majority of the cells still express EpCAM (A)
and Sox2 (B) as Sox2 and Lhx3/nestin double positive cells (A–C). Cell aggre-
gates often contain ACTH-positive cells (D), dispersed GSU-positive cells (E),
and rare Pit-1-positive cells (F) increasing at day 12. (G) GH-positive soma-
totrophs. (H) PRL-positive lactotrophs. (I) TSH-positive thyrotrophs. (Scale
bars: A, 70 m; B, 35 m; C and F, 100 m; D and E, 10 m; the bar in E
corresponds to 5 m in G–I.
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Fig. 4. Nestin-GFP-positive cells in the pituitary tumor. (A and B) Pituitary
tumor in a 12-month-old mouse that was Rb/ and carried the nestin-GFP
transgene. A macro view (A) and section of the organ (B, H&E) show that the
tumor consisted of multiple foci of endocrine proliferating cells arisen in the
intermediate lobe that compressed both posterior and intermediate lobes.
Divided cells are frequently seen in these nodules (B, H&E). Tu, tumor. [Scale
bars: 400 m (Left) and 20 m (Right).] (C–F) Distribution and phenotype of
nestin-GFP-positive cells inside pituitary tumor. Nestin-GFP-positive cells are
located mostly on the periphery of tumor nodules (C). They are positive for
Lhx3, EpCAM (D), Sox2 (E), and keratin 8 (F), but, in contrast to the majority of
tumor cells, they are negative for MSH (F). [Scale bars: 80 m (C) and 20 m
(D–F).]
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multipotent stem cells: (i) these cells can effectively self-renew
in culture; (ii) they can generate cells bearing the markers of
all terminally differentiated anterior pituitary lineages in vivo
and in vitro; (iii) they reside in a niche, the perilumenal region
of the gland; (iv) they contribute significantly to the expansion
of all terminally differentiated endocrine pituitary cell types
during the postnatal period of pituitary growth; (v) they
express key transcription factors that determine pituitary
development; (vi) they express nestin, which is a hallmark of
an increasing number of adult tissue-specific stem cells; (vii)
they represent only a small fraction of cells in the developing
pituitary gland, appear later than the embryonic precursors,
do not express several important markers of the embryonic
pituitary precursors, and contribute minimally to the pituitary
of the newborn, all features consistent with their role as stem
cells for the adult but not embryonic tissue; and (viii) a small
number of cells with the same phenotype reside inside pitu-
itary tumors, compatible with the possibility that they repre-
sent tumor stem cells.
Our data suggest that adult stem cells of the anterior
pituitary do not play a significant role in the embryonic
development of the anterior pituitary, but start functioning
and contributing prominently to the gland soon after birth.
This is compatible with the emerging evidence that a popu-
lation of adult stem cells can be maintained and function only
after a specific niche is established in the appropriate tissue
(33–35). Once entrenched in the niche (in this case, the
perilumenal region), these stem cells start to produce progeny
that can differentiate along the same lineages as embryonically
derived cells and colonize the organ. Thus, soon after birth and
throughout adulthood the gland represents a mosaic of dif-
ferentiated cells with similar phenotypes but of different
origin, i.e., those that were generated by the nestin/Lhx3/
Lhx4/Hesx1 embryonic precursors and those that were
produced by nestin/Lhx3/Lhx4/Hesx1 multipotent adult
stem cells (Fig. 5).
What could be the physiological implications of generating
parallel sets of terminally differentiated hormone-producing
cells from two different sources hosted by the same organ? It is
conceivable that differentiated endocrine cells derived postna-
tally from multipotential stem cells may be better suited to
function in a dynamic fashion in response to the constantly
changing hormonal and metabolical landscape of an adult
organism. This hypothesis would predict that there are subtle but
crucial differences between the two (embryonically derived and
adult stem cell-derived) populations of differentiated cells in the
anterior pituitary; indeed, there is accumulating evidence in
support of this idea. For instance, a physiological heterogeneity
has been found in the adult pituitary gland where a spatially
distinct subset of somatotrophs expresses the receptor for
GHRH. Single-point mutation in the gene coding for this
receptor resulted in growth retardation accompanied by loss of
this subpopulation of somatotrophs (36). Another example is
described for rats where a distinct subset of lactotrophs increases
with age in females, reaching a peak at the time of sexual
maturity (7). Likewise, the mosaic organization of the pituitary
gland may explain recent observations that conditional ablation
of the cAMP response element binding protein (CREB-1) using
nestin-Cre-mediated recombination (the same nestin-Cre line as
used in our experiments) results in adult onset of pituitary
hypoplasia accompanied by dwarfism (37). Importantly, the
embryonic development of the pituitary was not affected, com-
patible with the notion of two similar but distinct populations of
somatotrophs in the adult gland.
Our results argue that the anterior pituitary exemplifies an
unusual strategy for using stem cells to maintain the tissue and
respond to incoming signals. This strategy differs from that of
tissues with dedicated stem cells (e.g., hematopoietic stem cells),
facultative stem cells (e.g., oval cells of the liver), or self-renewal
of fully differentiated cells (e.g., hepatocytes). The parallel
activity of adult stem cells and embryonic precursors causes the
adult anterior pituitary to become a mosaic of terminally
differentiated cells of different origin with different life histories.
This may make the gland better adapted for dynamic responses
to physiological and pathological stimuli.
Materials and Methods
Animals. All experiments were performed by using C57B6 mice and nestin-
GFP transgenic mice (17) crossed to C57B6 for at least 10 generations.
Nestin-Cre transgenic mice [B6.Cg-Tg(Nes-cre)1Kln/J], ROSA-lsl-GFP
[Gt(ROSA)26Sortm2Sho] reporter mice, and Rb/ (B6.129S2-Rb1tm1Tyj/J)
mice were obtained from The Jackson Laboratory. Generation of Nestin-
CreER mice is described in ref. 28. Use of animals was reviewed and
approved by the Cold Spring Harbor Laboratory Animal Use and Care
Committee.
Immunocytochemistry. Immunolabeling was performed by following standard
protocols for tissue fixation and processing (see SI Text for details).
Tissue Culture. Pituitaries from wild-type or transgenic mice were dissociated,
and cells were plated at low density and grown in the presence of 20 ng/ml
bFGF and 50 ng/ml cholera toxin (see SI Text for details).
Real-Time Quantitative PCR. Experiments and statistical analysis of the results
were performed as described previously (38) (see SI Text and Tables S1 and S2
for the procedure details and the list of primers).
Additional Details. The remaining experimental details can be found in SI Text.
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Fig. 5. Schematic representation of the anterior pituitary histogenesis.
Anterior pituitary develops from the epithelial primordium (Rathke’s pouch),
influenced by the contact with ventral diencephalon and regulated by a
complex morphogenetic field of growth factors/morphogens. Around embry-
onic day 11, presumptive adult stem cells arise in the primordium of the
anterior pituitary. They reside mostly in the perilumenal area and, although
normally quiescent, possess high proliferative potential and the ability to
generate all terminally differentiated cell types in response to specific phys-
iological stimuli. During postnatal development, they contribute to all of the
terminally differentiated endocrine cell types of the anterior pituitary. As a
result, the adult anterior pituitary gland became a mosaic of terminally
differentiated cells of different origin and with a different life history.
6336  www.pnas.orgcgidoi10.1073pnas.0801644105 Gleiberman et al.
1. Morrison SJ, Kimble J (2006) Asymmetric and symmetric stem-cell divisions in devel-
opment and cancer. Nature 441:1068–1074.
2. Rawlins EL, Hogan BL (2006) Epithelial stem cells of the lung: Privileged few or
opportunities for many? Development 133:2455–2465.
3. Rosenfeld MG, et al. (2000) Multistep signaling and transcriptional requirements for
pituitary organogenesis in vivo. Recent Prog Horm Res 55:1–13; discussion 13–14.
4. Scully KM, Rosenfeld MG (2002) Pituitary development: Regulatory codes in mamma-
lian organogenesis. Science 295:2231–2235.
5. Carbajo-Perez E, Watanabe YG (1990) Cellular proliferation in the anterior pituitary of
the rat during the postnatal period. Cell Tissue Res 261:333–338.
6. Taniguchi Y, Yasutaka S, Kominami R, Shinohara H (2002) Proliferation and differen-
tiation of rat anterior pituitary cells. Anat Embryol (Berlin) 206:1–11.
7. Fiordelisio T, Hernandez-Cruz A (2002) Oestrogen regulates neurofilament expression
in a subset of anterior pituitary cells of the adult female rat. J Neuroendocrinol
14:411–424.
8. Asa SL, Ezzat S (2002) The pathogenesis of pituitary tumours. Nat Rev Cancer 2:836–
849.
9. Melmed S (2003) Mechanisms for pituitary tumorigenesis: The plastic pituitary. J Clin
Invest 112:1603–1618.
10. Inoue K, Mogi C, Ogawa S, Tomida M, Miyai S (2002) Are folliculo-stellate cells in the
anterior pituitary gland supportive cells or organ-specific stem cells? Arch Physiol
Biochem 110:50–53.
11. Horvath E, Kovacs K (2002) Folliculo-stellate cells of the human pituitary: A type of
adult stem cell? Ultrastruct Pathol 26:219–228.
12. Allaerts W, Vankelecom H (2005) History and perspectives of pituitary folliculo-stellate
cell research. Eur J Endocrinol 153:1–12.
13. Lepore DA, et al. (2005) Identification and enrichment of colony-forming cells from the
adult murine pituitary. Exp Cell Res 308:166–176.
14. Krylyshkina O, Chen J, Mebis L, Denef C, Vankelecom H (2005) Nestin-immunoreactive
cells in rat pituitary are neither hormonal nor typical folliculo-stellate cells. Endocri-
nology 146:2376–2387.
15. Chen J, et al. (2005) The adult pituitary contains a cell population displaying stem/
progenitor cell and early embryonic characteristics. Endocrinology 46:3985–3998.
16. Vankelecom H (2007) Stem cells in the postnatal pituitary? Neuroendocrinology
85:110–130.
17. Mignone JL, Kukekov V, Chiang AS, Steindler D, Enikolopov G (2004) Neural stem and
progenitor cells in nestin-GFP transgenic mice. J Comp Neurol 469:311–324.
18. Li L,et al. (2003) Nestin expression in hair follicle sheath progenitor cells.ProcNatlAcad
Sci USA 100:9958–9961.
19. Mignone JL, et al. (2007) Neural potential of a stem cells population in the hair follicle.
Cell Cycle 6:2161–2170.
20. Davidoff MS, et al. (2004) Progenitor cells of the testosterone-producing Leydig cells
revealed. J Cell Biol 167:935–944.
21. Day K, Shefer G, Richardson JB, Enikolopov G, Yablonka-Reuveni Z (2007) Nestin-GFP
reporter expression defines the quiescent state of skeletal muscle satellite cells. Dev
Biol 304:246–259.
22. Gleiberman AS, et al. (2005) Expression of nestin-green fluorescent protein transgene
marks oval cells in the adult liver. Dev Dyn 234:413–421.
23. Encinas JM, Vaahtokari A, Enikolopov G (2006) Fluoxetine targets early progenitor cells
in the adult brain. Proc Natl Acad Sci USA 103:8233–8238.
24. Sheng HZ, et al. (1996) Specification of pituitary cell lineages by the LIM homeobox
gene Lhx3. Science 272:1004–1007.
25. Bach I, et al. (1995) P-Lim, a LIM homeodomain factor, is expressed during pituitary
organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci USA 92:2720–
2724.
26. Tronche F, et al. (1999) Disruption of the glucocorticoid receptor gene in the nervous
system results in reduced anxiety. Nat Genet 23:99–103.
27. Joyner AL, Zervas M (2006) Genetic inducible fate mapping in mouse: Establishing
genetic lineages and defining genetic neuroanatomy in the nervous system. Dev Dyn
235:2376–2385.
28. Balordi F, Fishell G (2007) Mosaic removal of hedgehog signaling in the adult SVZ
reveals that the residual wild-type stem cells have a limited capacity for self-renewal.
J Neurosci 27:14248–14259.
29. Lobo NA, Shimono Y, Qian D, Clarke MF (2007) The biology of cancer stem cells. Annu
Rev Cell Dev Biol 23:675–699.
30. Tan BT, Park CY, Ailles LE, Weissman IL (2006) The cancer stem cell hypothesis: A work
in progress. Lab Invest 86:1203–1207.
31. Nikitin A, Lee WH (1996) Early loss of the retinoblastoma gene is associated with
impaired growth inhibitory innervation during melanotroph carcinogenesis in Rb/-
mice. Genes Dev 10:1870–1879.
32. Nikitin AY, Jua´rez-Pe´rez MI, Li S, Huang L, Lee WH (1999) RB-mediated suppression of
spontaneous multiple neuroendocrine neoplasia and lung metastases in Rb/mice.
Proc Natl Acad Sci USA 96:3916–3921.
33. Scadden DT (2006) The stem-cell niche as an entity of action. Nature 441:1075–1079.
34. Licinio J, Wong ML (2005) Depression, antidepressants and suicidality: A critical ap-
praisal. Nat Rev Drug Discovery 4:165–171.
35. Fuchs E, Tumbar T, Guasch G (2004) Socializing with the neighbors: Stem cells and their
niche. Cell 116:769–778.
36. Lin SC, et al. (1993) Molecular basis of the little mouse phenotype and implications for
cell type-specific growth. Nature 364:208–213.
37. Mantamadiotis T, et al. (2006) Hypothalamic 3,5-cyclic adenosine monophosphate
response element-binding protein loss causes anterior pituitary hypoplasia and dwarf-
ism in mice. Mol Endocrinol 20:204–211.
38. Hemish J, Nakaya N, Mittal V, Enikolopov G (2003) Nitric oxide activates diverse
signaling pathways to regulate gene expression. J Biol Chem 278:42321–42329.
Gleiberman et al. PNAS  April 29, 2008  vol. 105  no. 17  6337
D
EV
EL
O
PM
EN
TA
L
BI
O
LO
G
Y
Corrections
DEVELOPMENTAL BIOLOGY. For the article ‘‘Genetic approaches
identify adult pituitary stem cells,’’ by Anatoli S. Gleiberman,
Tatyana Michurina, Juan M. Encinas, Jose L. Roig, Peter
Krasnov, Francesca Balordi, Gord Fishell, Michael G. Rosen-
feld, and Grigori Enikolopov, which appeared in issue 17, April
29, 2008, of Proc Natl Acad Sci USA (105:6332–6337; first
published April 24, 2008; 10.1073pnas.0801644105), the au-
thors note the following: ‘‘We regret that we did not insert a
reference to the important manuscript by Fauquier et al. [Fau-
quier T, Rizzoti K, Dattani M, Lovell-Badge R, Robinson ICAF
(2008) Proc Natl Acad Sci USA 105:2907–2912], which published
while our manuscript was under review, into the final galley
revision of our manuscript. Fauquier et al. demonstrate that
adult pituitary contains Sox2-positive cells that, upon cultivation
in vitro, can generate differentiated pituitary lineages.’’
www.pnas.orgcgidoi10.1073pnas.0805200105
MEDICAL SCIENCES. For the article ‘‘Next generation of adeno-
associated virus 2 vectors: Point mutations in tyrosines lead to
high-efficiency transduction at lower doses,’’ by Li Zhong,
Baozheng Li, Cathryn S. Mah, Lakshmanan Govindasamy,
Mavis Agbandje-McKenna, Mario Cooper, Roland W. Herzog,
Irene Zolotukhin, Kenneth H. Warrington, Jr., Kirsten A.
Weigel-Van Aken, Jacqueline A. Hobbs, Sergei Zolotukhin,
Nicholas Muzyczka, and Arun Srivastava, which appeared in
issue 22, June 3, 2008, of Proc Natl Acad Sci USA (105:7827–
7832; first published May 29, 2008; 10.1073pnas.0802866105),
the authors note that on page 7831, right column, in Isolation of
Nuclear and Cytoplasmic Fractions fromHeLa Cells, line 3, V444F
should appear as Y444F. This error does not affect the conclu-
sions of the article.
www.pnas.orgcgidoi10.1073pnas.0806067105
MEDICAL SCIENCES. For the article ‘‘The lipofuscin fluorophore
A2E perturbs cholesterol metabolism in retinal pigment epithe-
lial cells,’’ by Aparna Lakkaraju, Silvia C. Finnemann, and
Enrique Rodriguez-Boulan, which appeared in issue 26, June 26,
2007, of Proc Natl Acad Sci USA (104:11026–11031; first pub-
lished June 19, 2007; 10.1073pnas.0702504104), the authors
note that the following grant was inadvertently omitted from the
Acknowledgments: American Health Assistance Foundation
Macular Degeneration Research Grant M2006-081 (to E.R.-B.).
www.pnas.orgcgidoi10.1073pnas.0805674105
NEUROSCIENCE. For the article ‘‘Activity of human hippocampal
and amygdala neurons during retrieval of declarativememories,’’
by Ueli Rutishauser, Erin M. Schuman, and Adam N. Mamelak,
which appeared in issue 1, January 8, 2008, of Proc Natl Acad Sci
USA (105:329–334; first published December 27, 2007; 10.1073
pnas.0706015105), the authors note that in Fig. 2, panels E and
F were transposed. The corrected figure and its legend appear
below.
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Fig. 2. Single-cell response. (A–C) Firing of a unit in the right hippocampus
that increases its firing in response to new stimuli that were correctly recog-
nized (novelty detector). (A) Raster of all trials during retrieval and the
waveforms associated with every spike. Trials: new (blue), old and recollected
(red, R), and old and not recollected (green, R). (B) Poststimulus time
histogram. (C) Mean number of spikes after stimulus onset. Firing was signif-
icantly larger in response to new stimuli, and the neuron fired more spikes in
response to stimuli that were later not recollected comparedwith stimuli that
were recollected. (D) The hypothesis: The less that novelty neurons fire, the
more likely it is that a stimulus will be recollected. The more that familiarity-
detecting neurons fire, the more likely it is that a stimulus will be recollected.
The dashed line indicates the baseline. (E and F) Normalized firing rate
(baseline  0) of all novelty (E) and familiarity-detecting (F) neurons during
above-chance sessions (30-min R). Novelty neurons firedmore in response to
not recollected items (R), whereas familiarity neurons firedmore in response
to recollected items (R). Errors are SEM.Number of trials, from left to right:
388, 79, 259, and 338 (E) and 132, 31, 96, and 127 (F).
www.pnas.orgcgidoi10.1073pnas.0805446105
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